Encapsulation of crosslinked subtilisin microcrystals in hydrogel beads for controlled release applications
- PMID: 17624742
- DOI: 10.1016/j.ejps.2007.05.003
Encapsulation of crosslinked subtilisin microcrystals in hydrogel beads for controlled release applications
Abstract
Enzymes are less stable in harsh conditions and hence to overcome this nature, several methodologies are being developed. It was found that crosslinked enzyme crystals are the most promising strategy for the stabilization of the enzymes [Emilia Abraham, T., Jegan Roy, J., Bindhu, L.V., Jayakumar, K.K., 2004. Crosslinked enzyme crystals of glucoamylase as a potent catalyst for biotransformations. Carbohydr. Res. 339, 1099-1104; Navia, M., St. Clair, N., 1997. Crosslinked enzyme crystals. Biosens. Bioelectron. 12, 7]. A cost effective methodology of crystallization of protease (Bacillus subtilis) with ammonium sulphate (65%, w/v) and then crosslinking the crystals with glutaraldehyde (4%, v/v) in isopropanol for 20min gave a stable and active enzyme. SEM studies showed that the protease is in small cubic shaped crystals of 1-2 microm size. Crosslinked enzyme crystal (CLEC) of protease has good stability in polar and nonpolar organic solvents, such as hexane, toluene, benzene and carbon tetrachloride and it had high thermal stability up to 60 degrees C and hence can be used as a catalyst for the biotransformation of compounds which are not soluble in aqueous medium. The CLECs were entrapped in the alginate:guar gum (3:1) composite beads which were resistant to low pH conditions in the stomach and hence was found to be useful for the oral drug delivery. This method can be used to deliver the protein and peptide drugs which require high concentrations at the delivery stage, and which normally degrades in the stomach before reaching the jejunum. Application of these pH-sensitive beads for the controlled release of subtilisin in in vitro was studied and found to be a viable strategy.
Similar articles
-
Preparation and characterization of cross-linked enzyme aggregates (CLEA) of subtilisin for controlled release applications.Int J Biol Macromol. 2008 Oct 1;43(3):314-9. doi: 10.1016/j.ijbiomac.2008.07.001. Epub 2008 Jul 9. Int J Biol Macromol. 2008. PMID: 18662715
-
pH sensitive alginate-guar gum hydrogel for the controlled delivery of protein drugs.Int J Pharm. 2007 Apr 20;335(1-2):123-129. doi: 10.1016/j.ijpharm.2006.11.009. Epub 2006 Nov 7. Int J Pharm. 2007. PMID: 17147980
-
Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs.Biomaterials. 2005 May;26(14):2105-13. doi: 10.1016/j.biomaterials.2004.06.011. Biomaterials. 2005. PMID: 15576185
-
Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.J Control Release. 2006 Aug 10;114(1):1-14. doi: 10.1016/j.jconrel.2006.04.017. Epub 2006 May 22. J Control Release. 2006. PMID: 16828914 Review.
-
Recent developments in superporous hydrogels.J Pharm Pharmacol. 2007 Mar;59(3):317-27. doi: 10.1211/jpp.59.3.0001. J Pharm Pharmacol. 2007. PMID: 17331335 Review.
Cited by
-
Alginates Combined with Natural Polymers as Valuable Drug Delivery Platforms.Mar Drugs. 2022 Dec 23;21(1):11. doi: 10.3390/md21010011. Mar Drugs. 2022. PMID: 36662184 Free PMC article. Review.
-
Alginate Particles as Platform for Drug Delivery by the Oral Route: State-of-the-Art.ISRN Pharm. 2014 Apr 9;2014:926157. doi: 10.1155/2014/926157. eCollection 2014. ISRN Pharm. 2014. PMID: 25101184 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources